Table 3.
Subgroups of eyes according to VA at baseline, 4, 12 and 24 months
| VA, letters | Group A (n = 115) | Group B (n = 33) | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 4 months | 12 months | 24 months | Baseline | 4 months | 12 months | 24 months | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| ≥70 | 24 (20.9) | 45 (39.1) | 56 (48.7) | 50 (43.5) | 9 (27.3) | 19 (57.6) | 19 (57.6) | 17 (51.5) |
| 55–69 | 51 (44.3) | 47 (40.9) | 29 (25.2) | 40 (34.8) | 17 (51.5) | 7 (21.2) | 8 (24.2) | 5 (15.2) |
| 35–54 | 30 (26.1) | 17 (14.8) | 25 (21.7) | 21 (18.3) | 6 (18.2) | 6 (18.2) | 5 (15.2) | 9 (27.3) |
| < 35 | 10 (8.7) | 6 (5.2) | 5 (4.3) | 4 (3.5) | 1 (3.0) | 1 (3.0) | 1 (3.0) | 2 (6.1) |
n: number of eyes. Group A: eyes receiving the TE regimen for 2 years; Group B: eyes receiving the TE regimen in Year 1 and the PRN regimen in Year 2. PRN: pro re nata; TE: treat-and-extend; VA: visual acuity